115 related articles for article (PubMed ID: 17684833)
21. More is not always better: cost-effectiveness analysis of combined, single behavioral and single physical rehabilitation programs for chronic low back pain.
Smeets RJ; Severens JL; Beelen S; Vlaeyen JW; Knottnerus JA
Eur J Pain; 2009 Jan; 13(1):71-81. PubMed ID: 18434221
[TBL] [Abstract][Full Text] [Related]
22. A value-based medicine analysis of ranibizumab for the treatment of subfoveal neovascular macular degeneration.
Brown MM; Brown GC; Brown HC; Peet J
Ophthalmology; 2008 Jun; 115(6):1039-1045.e5. PubMed ID: 17976724
[TBL] [Abstract][Full Text] [Related]
23. A computer method for assessing satisfaction with hearing aids.
Cienkowski KM; McHugh MS; McHugo GJ; Musiek FE; Cox RM; Baird JC
Int J Audiol; 2006 Jul; 45(7):393-9. PubMed ID: 16938797
[TBL] [Abstract][Full Text] [Related]
24. A comparison of SF-6D and EQ-5D utility scores in a study of patients with schizophrenia.
McCrone P; Patel A; Knapp M; Schene A; Koeter M; Amaddeo F; Ruggeri M; Giessler A; Puschner B; Thornicroft G
J Ment Health Policy Econ; 2009 Mar; 12(1):27-31. PubMed ID: 19346564
[TBL] [Abstract][Full Text] [Related]
25. Factors influencing rehabilitation decisions of adults with acquired hearing impairment.
Laplante-Lévesque A; Hickson L; Worrall L
Int J Audiol; 2010 Jul; 49(7):497-507. PubMed ID: 20528667
[TBL] [Abstract][Full Text] [Related]
26. Candidacy for bilateral hearing aids: a retrospective multicenter study.
Boymans M; Goverts ST; Kramer SE; Festen JM; Dreschler WA
J Speech Lang Hear Res; 2009 Feb; 52(1):130-40. PubMed ID: 18664691
[TBL] [Abstract][Full Text] [Related]
27. [Cost-utility analysis of ranibizumab (Lucentis) in neovascular macular degeneration].
Neubauer AS; Holz FG; Schrader W; Back EI; Kühn T; Hirneiss C; Kampik A
Klin Monbl Augenheilkd; 2007 Sep; 224(9):727-32. PubMed ID: 17846963
[TBL] [Abstract][Full Text] [Related]
28. Hearing aids. Choices for every need.
Mayo Clin Health Lett; 2003 Dec; 21(12):4-5. PubMed ID: 14971351
[No Abstract] [Full Text] [Related]
29. Provision of hearing aids to children in Bangladesh: costs and cost-effectiveness of a community-based and a centre-based approach.
Ekman B; Borg J
Disabil Rehabil Assist Technol; 2017 Aug; 12(6):625-630. PubMed ID: 27498947
[TBL] [Abstract][Full Text] [Related]
30. The application of self-efficacy principles to audiologic rehabilitation: a tutorial.
Smith SL; West RL
Am J Audiol; 2006 Jun; 15(1):46-56. PubMed ID: 16803791
[TBL] [Abstract][Full Text] [Related]
31. Cost-effectiveness and quality-of-life analysis of physician-staffed helicopter emergency medical services.
Ringburg AN; Polinder S; Meulman TJ; Steyerberg EW; van Lieshout EM; Patka P; van Beeck EF; Schipper IB
Br J Surg; 2009 Nov; 96(11):1365-70. PubMed ID: 19847879
[TBL] [Abstract][Full Text] [Related]
32. Combination therapy (intratympanic dexamethasone + high-dose prednisone taper) for the treatment of idiopathic sudden sensorineural hearing loss.
Battaglia A; Burchette R; Cueva R
Otol Neurotol; 2008 Jun; 29(4):453-60. PubMed ID: 18401285
[TBL] [Abstract][Full Text] [Related]
33. The value-based medicine comparative effectiveness and cost-effectiveness of penetrating keratoplasty for keratoconus.
Roe RH; Lass JH; Brown GC; Brown MM
Cornea; 2008 Oct; 27(9):1001-7. PubMed ID: 18812762
[TBL] [Abstract][Full Text] [Related]
34. Longitudinal benefit from and satisfaction with the Baha system for patients with acquired unilateral sensorineural hearing loss.
Newman CW; Sandridge SA; Wodzisz LM
Otol Neurotol; 2008 Dec; 29(8):1123-31. PubMed ID: 19034196
[TBL] [Abstract][Full Text] [Related]
35. The cost-effectiveness of routine office-based identification and subsequent medical treatment of primary open-angle glaucoma in the United States.
Rein DB; Wittenborn JS; Lee PP; Wirth KE; Sorensen SW; Hoerger TJ; Saaddine JB
Ophthalmology; 2009 May; 116(5):823-32. PubMed ID: 19285730
[TBL] [Abstract][Full Text] [Related]
36. Development and initial validation of the 'Clinical Global Impression' to measure outcomes for audiological rehabilitation.
Oberg M; Wänström G; Hjertman H; Lunner T; Andersson G
Disabil Rehabil; 2009; 31(17):1409-17. PubMed ID: 19479578
[TBL] [Abstract][Full Text] [Related]
37. Cost-utility analysis of treatment strategies in patients with recent-onset rheumatoid arthritis.
van den Hout WB; Goekoop-Ruiterman YP; Allaart CF; de Vries-Bouwstra JK; Hazes JM; Kerstens PJ; van Zeben D; Hulsmans HM; de Jonge-Bok JM; de Sonnaville PB; Dijkmans BA; Breedveld FC
Arthritis Rheum; 2009 Mar; 61(3):291-9. PubMed ID: 19248130
[TBL] [Abstract][Full Text] [Related]
38. Age-related use and benefit of the bone-anchored hearing aid compact.
de Wolf MJ; Leijendeckers JM; Mylanus EA; Hol MK; Snik AF; Cremers CW
Otol Neurotol; 2009 Sep; 30(6):787-92. PubMed ID: 19638942
[TBL] [Abstract][Full Text] [Related]
39. A value-based medicine cost-utility analysis of idiopathic epiretinal membrane surgery.
Gupta OP; Brown GC; Brown MM
Am J Ophthalmol; 2008 May; 145(5):923-8. PubMed ID: 18329000
[TBL] [Abstract][Full Text] [Related]
40. Hearing aids and tinnitus therapy: a 25-year experience.
Trotter MI; Donaldson I
J Laryngol Otol; 2008 Oct; 122(10):1052-6. PubMed ID: 18353195
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
